Hui Lin
-
- Cardiac Arrhythmias and Treatments 10
- Atrial Fibrillation Management and Outcomes 8
- Cardiac pacing and defibrillation studies 6
- Chemotherapy-induced cardiotoxicity and mitigation 5
- Cardiovascular Function and Risk Factors 3
- Nephrology top 5%
- Chronic Kidney Disease and Diabetes 3
- Cancer Research top 10%
- Clinical Biochemistry top 5%
- Geriatrics and Gerontology top 10%
-
- Autophagy in Disease and Therapy 4
-
- RNA modifications and cancer 3
In The Last Decade
Hui Lin
66 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 99
- Cardiology and Cardiovascular Medicine 405
- Nephrology 122
- Cancer Research 179
- Clinical Biochemistry 75
- Geriatrics and Gerontology 40
Countries citing papers authored by Hui Lin
This map shows the geographic impact of Hui Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Lin more than expected).
Fields of papers citing papers by Hui Lin
This network shows the impact of papers produced by Hui Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Lin. The network helps show where Hui Lin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hui Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 5 | |
| 5 | 2023 | 16 | |
| 6 | 2023 | 7 | |
| 7 | 2022 | 2 | |
| 8 | 2022 | 11 | |
| 9 | 2020 | 101 | |
| 10 | 2020 | 47 | |
| 11 | 2019 | 12 | |
| 12 | 2019 | 98 | |
| 13 | 2017 | 44 | |
| 14 | 2017 | 1 | |
| 15 | 2013 | 37 | |
| 16 | 2012 | 23 | |
| 17 | 2007 | 21 | |
| 18 | 2006 | 27 | |
| 19 | [The relationship between prognosis, metastasis and microvessel quantity in invasive breast carcinoma]. | 1997 | 0 |
| 20 | Effects of cyclophosphamide(cy), 1,3-bis(2-cholroethyl)-1-nitrosourea (bcnu), vinblastine(vlb) and cytosine arabinoside(ara-c) on lymphoma cells from the spontaneous lymphoma of akr mice. Abstr. | 1969 | 1 |
About Hui Lin
Hui Lin is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology, Cancer Research, Pharmacology and Clinical Biochemistry, having authored 73 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cardiac Arrhythmias and Treatments (10 papers), Atrial Fibrillation Management and Outcomes (8 papers), Cardiac pacing and defibrillation studies (6 papers), Chemotherapy-induced cardiotoxicity and mitigation (5 papers), Autophagy in Disease and Therapy (4 papers), RNA modifications and cancer (3 papers), Cardiovascular Function and Risk Factors (3 papers) and Chronic Kidney Disease and Diabetes (3 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (405 citations), Nephrology (122 citations), Cancer Research (179 citations), Clinical Biochemistry (75 citations) and Geriatrics and Gerontology (40 citations). Hui Lin has collaborated with scholars based in China, Estonia and Japan. Frequent co-authors include Liping Meng, Tingjuan Ni, Zhenzhu Sun, Hangyuan Guo, Xingxiao Huang, Jie Zhang, Jufang Chi, Hangyuan Guo, Feidan Gao and Wenqiang Lu. Their work appears in journals such as Scientific Reports, Frontiers in Pharmacology, Antioxidants and Redox Signaling, Cardiovascular Drugs and Therapy and EP Europace.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.